Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors
- PMID: 23860966
- DOI: 10.1007/s10897-013-9613-3
Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors
Abstract
Identification and comprehensive care of individuals who have Fabry disease (FD) requires a multidisciplinary approach inclusive of genetic testing, test interpretation, genetic counseling, long term disease symptom monitoring, treatment recommendations, and coordination of therapy. The purpose of this document is to provide health care professionals with guidelines for testing, care coordination, identification of psychosocial issues, and to facilitate a better understanding of disease treatment expert recommendations for patients with Fabry disease. These recommendations are the opinions of a multicenter working group of genetic counselors, medical geneticists, and other health professionals with expertise in Fabry disease counseling, as well as representatives/founders of the two United States based Fabry disease patient advocacy groups who are themselves affected by Fabry disease. The recommendations are U.S. Preventive Task Force Class III, and they are based on clinical experience, a review of pertinent English-language articles, and reports of expert committees. This document reviews the genetics of Fabry disease, the indications for genetic testing, interpretation of results, psychosocial considerations, and references to professional and patient resources.
Similar articles
-
Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.J Genet Couns. 2002 Apr;11(2):121-46. doi: 10.1023/a:1014545521753. J Genet Couns. 2002. PMID: 12735292
-
[Fabry disease--guidelines for diagnosis and management of adult patients].Lijec Vjesn. 2014 May-Jun;136(5-6):133-5. Lijec Vjesn. 2014. PMID: 25154181 Croatian.
-
Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.J Genet Couns. 2005 Jun;14(3):165-81. doi: 10.1007/s10897-005-3241-5. J Genet Couns. 2005. PMID: 15959648
-
Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.J Genet Couns. 2007 Aug;16(4):387-407. doi: 10.1007/s10897-007-9101-8. Epub 2007 Jul 17. J Genet Couns. 2007. PMID: 17636453 Free PMC article. Review.
-
[Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].Presse Med. 2007 Jul-Aug;36(7-8):1084-97. doi: 10.1016/j.lpm.2007.01.006. Epub 2007 Feb 2. Presse Med. 2007. PMID: 17276649 Review. French.
Cited by
-
Effectiveness and safety of enzyme replacement therapy in the treatment of Fabry disease: a Chinese monocentric real-world study.Orphanet J Rare Dis. 2024 Nov 11;19(1):422. doi: 10.1186/s13023-024-03441-1. Orphanet J Rare Dis. 2024. PMID: 39529120 Free PMC article.
-
Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease.Int J Mol Sci. 2024 Jul 29;25(15):8273. doi: 10.3390/ijms25158273. Int J Mol Sci. 2024. PMID: 39125842 Free PMC article. Review.
-
Cochleovestibular Signs As the First Manifestation of Fabry Disease: A Case Report and Literature Review.Cureus. 2024 Mar 30;16(3):e57289. doi: 10.7759/cureus.57289. eCollection 2024 Mar. Cureus. 2024. PMID: 38690505 Free PMC article.
-
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.Genes (Basel). 2023 Dec 26;15(1):37. doi: 10.3390/genes15010037. Genes (Basel). 2023. PMID: 38254927 Free PMC article. Review.
-
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.BMC Nephrol. 2023 Nov 21;24(1):344. doi: 10.1186/s12882-023-03388-8. BMC Nephrol. 2023. PMID: 37990184 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
